RESOURCES

Technical Notes

A Systematic Approach for Generation and Qualification of New Lots of Negative Control for Supporting Immunogenicity Assays

Kim Krug, M.S., Amy Rosen, M.S., Tyler Ison, M.S., Ronald R. Bowsher, Ph.D.

2021

B2S Cut Point Statistics FACT Sheet_2026

2026

B2S Life Sciences’ experts are here to help!

B2S staff member smiling

    * Required fields

    B2S Life Sciences – A biotherapeutic enablement company advancing improved analytical methods and outcomes for developers of biotherapeutic drugs and diagnostics. We leverage extensive expertise in bioanalytical method development and statistical analysis for superior custom reagent products and services, tailored to our clients’ needs.

    ©2026 B2S Life Science. All Rights Reserved.

    Website design by Mentus

    ©2026 B2S Life Science. All Rights Reserved.

    Website design by Mentus